Smith J B, Ingerman C, Kocsis J J, Silver M J
J Clin Invest. 1974 May;53(5):1468-72. doi: 10.1172/JCI107695.
A compound that could be converted to prostaglandin F(2alpha) by mild chemical reduction was formed by human platelets in response to arachidonic acid, collagen, or L-epinephrine. It was present in maximal amounts at about 1 min after addition of arachidonic acid or collagen to platelet-rich plasma. Its initial formation appeared to precede platelet aggregation by these agents and was closely correlated with the release of adenine nucleotides and radioactive 5-hydroxytryptamine from platelets. Moreover, the compound was itself found outside the platelets. This compound is probably an endoperoxide intermediate in prostaglandin biosynthesis and may be a trigger for the platelet release reaction.
一种可通过温和化学还原转化为前列腺素F(2α)的化合物,由人血小板在花生四烯酸、胶原或L-肾上腺素作用下形成。在向富含血小板的血浆中添加花生四烯酸或胶原后约1分钟时,其含量达到最高。这些物质最初形成似乎先于血小板聚集,并且与血小板中腺嘌呤核苷酸和放射性5-羟色胺的释放密切相关。此外,该化合物本身也存在于血小板外。这种化合物可能是前列腺素生物合成中的一种内过氧化物中间体,可能是血小板释放反应的触发因素。